Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,650

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Breast CancerRadiotherapy; ComplicationsEffect of Radiation Therapy
Interventions
RADIATION

Entire supraclavicular lymph node radiotherapy

Radiation is delivered to the breast/chest wall, undissected axilla, internal mammary nodes and entire supraclavicular lymph node. Entire supraclavicular lymph node includes medial supraclavicular and posterior neck lymph node.

RADIATION

Medial supraclavicular lymph node radiotherapy

Radiation is delivered to the breast/chest wall, undissected axilla, internal mammary nodes and entire supraclavicular lymph node.

Trial Locations (1)

Unknown

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
collaborator

The First Affiliated Hospital of University of Science and Technology of China

OTHER

collaborator

Quanzhou First Hospital

OTHER

collaborator

Jiangyin People's Hospital

OTHER

collaborator

Affiliated Hospital of Jiangnan University

OTHER

collaborator

Guizhou Provincial People's Hospital

OTHER

lead

Fudan University

OTHER